Fiduciary Group LLC decreased its position in shares of Clorox Co (NYSE:CLX) by 2.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,633 shares of the company’s stock after selling 225 shares during the period. Fiduciary Group LLC’s holdings in Clorox were worth $1,475,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Zions Bancorporation N.A. acquired a new stake in shares of Clorox during the first quarter worth approximately $28,000. Northstar Capital Management LLC acquired a new stake in shares of Clorox in the first quarter valued at approximately $29,000. Penserra Capital Management LLC acquired a new stake in shares of Clorox in the first quarter valued at approximately $36,000. Trustcore Financial Services LLC acquired a new stake in shares of Clorox in the first quarter valued at approximately $38,000. Finally, Rational Advisors LLC increased its holdings in shares of Clorox by 59.5% in the first quarter. Rational Advisors LLC now owns 276 shares of the company’s stock valued at $44,000 after purchasing an additional 103 shares in the last quarter. 75.88% of the stock is owned by institutional investors.
A number of analysts recently weighed in on the stock. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price target for the company in a report on Monday, July 29th. Deutsche Bank raised shares of Clorox from a “sell” rating to a “hold” rating and set a $139.00 price target for the company in a report on Thursday, May 2nd. Bank of America reissued a “neutral” rating and issued a $154.00 price target (down previously from $165.00) on shares of Clorox in a report on Thursday, May 2nd. BMO Capital Markets set a $168.00 price target on shares of Clorox and gave the company a “buy” rating in a report on Thursday, May 2nd. Finally, Argus lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Monday, May 20th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company’s stock. Clorox has an average rating of “Hold” and an average target price of $154.07.
In other Clorox news, SVP Diego J. Barral sold 1,987 shares of the firm’s stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $157.59, for a total value of $313,131.33. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director A D. David Mackay sold 3,400 shares of Clorox stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $154.87, for a total transaction of $526,558.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 25,786 shares of company stock worth $4,054,776. Insiders own 1.40% of the company’s stock.
CLX stock traded up $0.20 during midday trading on Monday, reaching $161.10. The company’s stock had a trading volume of 5,643 shares, compared to its average volume of 1,081,260. Clorox Co has a 52 week low of $141.53 and a 52 week high of $167.70. The stock has a market cap of $20.50 billion, a PE ratio of 25.54, a price-to-earnings-growth ratio of 5.00 and a beta of 0.37. The company has a quick ratio of 0.55, a current ratio of 0.91 and a debt-to-equity ratio of 4.09. The business’s 50-day simple moving average is $158.74 and its 200-day simple moving average is $155.63.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The firm had revenue of $1.63 billion for the quarter, compared to analysts’ expectations of $1.69 billion. During the same period last year, the firm earned $1.66 earnings per share. The business’s revenue for the quarter was down 3.8% on a year-over-year basis. As a group, equities analysts forecast that Clorox Co will post 6.4 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Shareholders of record on Wednesday, July 31st were paid a $1.06 dividend. The ex-dividend date of this dividend was Tuesday, July 30th. This is a boost from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 dividend on an annualized basis and a yield of 2.63%. Clorox’s dividend payout ratio (DPR) is presently 67.09%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: Quantitative Easing
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.